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METHODS

PROBLEM
Hospitalized patients with blood stream
infections (BSIs) are at increased morbidity and
mortality risk despite advances in therapy and
overall care.1

Retrospective review of 100 adult BSI patients
in Advocate Aurora Health (Legacy WI) with a
positive blood culture from April 1 – June 30,
2019.

CONCLUSIONS
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Audit and provider feedback for positive blood
cultures by pharmacists has been shown to
improve care and outcomes for BSI patients.
• However, previous studies employed
pharmacy specialists with infectious
diseases (ID) training in a centralized audit
and feedback model1
It is unknown if decentralized, inpatient
pharmacists, with support from ID pharmacists
as needed, could impact patient care similarly.

Data collected included patient demographics,
blood culture draw time, culture results (gram
stain, pathogen, antibiotic susceptibilities), time
to empiric therapy start and time to antibiotic
optimization.
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Outcomes collected were compared to
previously published studies.1

BSI audit and provider feedback by decentralized, inpatient pharmacists, with as
needed support from ID pharmacists, may
represent an alternative to centralized ID
pharmacist model.

Streptococcus spp.

Primary Outcome: Time from blood culture
draw to effective empiric antimicrobial therapy.2
Secondary Outcome: Time from blood culture
draw to optimal antimicrobial therapy.2

These results are similar to previously published
studies of ID pharmacy specialists in a
centralized audit and feedback model.

• Gram-negative isolate: 61%
• Multi-drug resistant pathogen: 8%

Table 2. Time to Therapy Outcomes

Application of these findings to practice will
allow for more efficient use of pharmacist time
and expand de-centralized, inpatient pharmacy
practice.

NEXT STEPS

BACKGROUND
Beganovic et al.1
(Legacy Advocate)
•

•

Real-time blood culture
surveillance done by
Infectious Diseases (ID)
pharmacists
Blood culture results &
updates paged to ID
pharmacists 24 hours, 7
days a week

Compare this data from Legacy
Wisconsin to similarly collected
Legacy Advocate data during the
same time frame with same data
points to inform one method of
pharmacist blood culture
surveillance moving forward.

Legacy Aurora
•

•

•

Blood culture surveillance
done by de-centralized
clinical pharmacists
Blood culture results &
updates sent in the form of
in-basket messages
through the electronic
health record (HER)
ID pharmacists available
as needed in this process

OBJECTIVE
To evaluate antibiotic treatment and
outcomes for BSI patients for whom
blood culture audit and provider
feedback was performed be
decentralized, inpatient
pharmacists.

RESULTS
Table 1. Patient Demographics

Figure 3. TTET and TTOT1,2
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